UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 332

Sortiert nach

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

Annals of oncology, 2014-02, Vol.25 (2), p.415-422

2014

Volltextzugriff (PDF)

A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer

Annals of oncology, 2012-08, Vol.23 (8), p.2094-2102

2012

Volltextzugriff (PDF)

Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer

Cancer chemotherapy and pharmacology, 2013, Vol.71 (1), p.115-121

2013

Volltextzugriff (PDF)

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

The New England journal of medicine, 2018-05, Vol.378 (22), p.2093-2104

2018

Volltextzugriff (PDF)

Erlotinib in African Americans With Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.182-191

2014

Volltextzugriff (PDF)

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer

Annals of oncology, 2002-04, Vol.13 (4), p.539-545

2002

Volltextzugriff (PDF)

An epigenetic mechanism for capecitabine resistance in mesothelioma

Biochemical and biophysical research communications, 2010-01, Vol.391 (3), p.1465-1470

2010

Volltextzugriff (PDF)

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

Biochemical and biophysical research communications, 2008-09, Vol.373 (4), p.607-612

2008

Volltextzugriff (PDF)

Expression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung Cancer

JNCI : Journal of the National Cancer Institute, 2004-11, Vol.96 (22), p.1718-1721

2004

Volltextzugriff (PDF)

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

Annals of oncology, 2008-11, Vol.19 (11), p.1903-1909

2008

Volltextzugriff (PDF)

Inhibition of Cyclin D-CDK4/CDK6 Activity is Associated with an E2F-Mediated Induction of Cyclin Kinase Inhibitor Activity

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4350-4354

1996

Volltextzugriff (PDF)

Immune related adverse events across cancer types: Incidence, risk factors and survival

Annals of oncology, 2018-10, Vol.29, p.viii630-viii631

2018

Volltextzugriff (PDF)

End of life resource utilization among patients receiving immunotherapy for advanced cancer

Annals of oncology, 2018-10, Vol.29, p.viii553-viii553

2018

Volltextzugriff (PDF)

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

ESMO open, 2023-04, Vol.8 (2), p.101183-101183, Article 101183

2023

Volltextzugriff (PDF)

Temperature-Sensitive RB Mutations Linked to Incomplete Penetrance of Familial Retinoblastoma in 12 Families

American journal of human genetics, 1999-10, Vol.65 (4), p.1040-1046

1999

Volltextzugriff (PDF)

DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (4), p.1327-1333

2001

Volltextzugriff (PDF)

Protein Expression and Functional Analysis of the FHIT Gene in Human Tumor Cells

JNCI : Journal of the National Cancer Institute, 1998-03, Vol.90 (6), p.426-432

1998

Volltextzugriff (PDF)

RT-PCR Heteroduplex Analysis Permits Differentiation of Transgene and Host Gene Expression in a Transgenic Animal Model

BioTechniques, 2002-07, Vol.33 (1), p.58-66

2002

Volltextzugriff (PDF)

The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro

Molecular and Cellular Biology, 1995-09, Vol.15 (9), p.5188-5195

1995

Volltextzugriff (PDF)

Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding

Oncogene, 1997-03, Vol.14 (10), p.1243-1248

1997

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors

Investigational new drugs, 2005-12, Vol.23 (6), p.555-562

2005

Volltextzugriff (PDF)

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth

Genes & development, 1998-01, Vol.12 (1), p.95-106

1998

Volltextzugriff (PDF)

RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer

Oncogene, 1998-09, Vol.17 (12), p.1625-1628

1998

Volltextzugriff (PDF)

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells

Oncogene, 2001-11, Vol.20 (53), p.7787-7796

2001

Volltextzugriff (PDF)

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

Biochemical and biophysical research communications, 2009-10, Vol.388 (3), p.483-489

2009

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)
Mit Volltextzugriff
(294)

Publikationsform

Sprache

Englisch
(331)
Japanisch
(27)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Humans
(140)
Life Sciences & Biomedicine
(138)
Biological And Medical Sciences
(68)
Female
(67)
Oncology
(64)
Male
(62)
Adult
(52)
Medical Sciences
(50)
Middle Aged
(50)
Aged
(43)
Lung Neoplasms - Pathology
(27)
Animals
(24)
Gastroenterology & Hepatology
(24)
Tumors
(24)
Biochemistry & Molecular Biology
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Lung Neoplasms - Genetics
(22)
Lung Cancer
(21)
Retrospective Studies
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer

Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Erlotinib in African Americans With Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study With Genetic and Pharmacokinetic Analyses

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer

An epigenetic mechanism for capecitabine resistance in mesothelioma

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

Expression of Pirh2, a Newly Identified Ubiquitin Protein Ligase, in Lung Cancer

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

Inhibition of Cyclin D-CDK4/CDK6 Activity is Associated with an E2F-Mediated Induction of Cyclin Kinase Inhibitor Activity

Immune related adverse events across cancer types: Incidence, risk factors and survival

End of life resource utilization among patients receiving immunotherapy for advanced cancer

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations

Temperature-Sensitive RB Mutations Linked to Incomplete Penetrance of Familial Retinoblastoma in 12 Families

DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors

Protein Expression and Functional Analysis of the FHIT Gene in Human Tumor Cells

RT-PCR Heteroduplex Analysis Permits Differentiation of Transgene and Host Gene Expression in a Transgenic Animal Model

The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro

Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding

A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth

RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer

Suchergebnisse filtern